thiotepa has been researched along with Myasthenia Gravis in 2 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bennett, EJ | 1 |
Schmidt, GB | 1 |
Patel, KP | 1 |
Grundy, EM | 1 |
Clement, JG | 1 |
2 other studies available for thiotepa and Myasthenia Gravis
Article | Year |
---|---|
Muscle relaxants, myasthenia, and mustards?
Topics: Drug Interactions; Female; Humans; Middle Aged; Muscle Relaxants, Central; Myasthenia Gravis; Nitrog | 1977 |
Neuromuscular blockade by nitrogen mustard.
Topics: Humans; Mechlorethamine; Myasthenia Gravis; Neuromuscular Blocking Agents; Thiotepa | 1977 |